POCKETGUIDE CKD
- Richtlinien zu Screening und Identifikation der Chronischen Niereninsuffizienz für Allgemeinmediziner und Internisten
- Screening and identification of Chronic Kidney Disease for general practitioners
- Recommandations pour le dépistage et l’identification de l’insuffisance rénale chronique (IRC) pour les médecins généralistes
- Raccomandazioni per l’identificazione della malattia renale cronica per medici generalisti
PUBLICATIONS
- Nephrology Worldwide
José A. Moura-Neto, José Carolino Divino-Filho, Claudio Ronco
Moura-Neto JA, Divino-Filho JC, Ronco C, editors. Nephrology Worldwide. Basel: Springer Nature Switzerland AG; 2021. 751 p.
https://doi.org/10.1007/978-3-030-56890-0 - Final Public Report EDITH (The Effect of Differing Kidney Disease Treatment Modalities and Organ Donation and Transplantation Practices on Health Expenditure and Patient Outcomes)
Chronic Kidney Disease (CKD) is the cause of substantial morbidity and mortality and results in major burden to both, individual patients and society as a whole. It has been estimated that about 10% of the population in Europe is affected by CKD and the number of patients is expected to grow as the prevalence of typical risk factors for CKD, such as diabetes and hypertension, is still increasing. CKD is divided into five stages, with stage I describing normal kidney functioning but evidence of kidney damage up to stage V representing kidney failure............. - Le progrès en néphrologie: bénéfique pour les patients et les coûts
Pierre-Yves Martin
Service de Néphrologie HUG, Président Société Suisse de Néphrologie (2017) - Fortschritte in der Nephrologie: Vorteilhaft für Patienten und Kosten
Pierre-Yves Martin
Nephrologische Abteilung HUG, Präsident der Schweizerischen Gesellschaft für Nephrologie (2017)
POSITION PAPERS / POSITIONSPAPIERE / PRESA DI POSIZIONI / PRISE DE POSITION
CHOOSING WISELY
At the request of the Swiss Academy of Medical Sciences, and noting the interest of the Swiss Academy for Quality in Medicine and a similar initiative of the Swiss Society of Internal Medicine, the Board of the Swiss Society of Nephrology joined the international campaign "Choosing Wisely ".
The campaign aims at promoting doctor-patient dialogue and contains medical guidelines in case of unfavorable individual risk-benefit balance.